Nucleic Acid Testing Industry Surges, Anticipated to Hit US$ 7.2 Billion by 2033″

The nucleic acid testing (NAT) industry stands as a revolutionary force in the realm of diagnostics, offering unparalleled insights into genetic information for a wide range of applications. NAT involves the detection and analysis of nucleic acids, such as DNA and RNA, to diagnose diseases, identify pathogens, and assess genetic predispositions. This sophisticated technology has transformed …